Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00112346. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Multicenter Phase II Study of Gemcitabine/Platinum/Cetuximab Versus Gemcitabine/Platinum as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
Study identification
- NCT ID
- NCT00112346
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- Cetuximab + platinum + gemcitabine Drug
- Platinum + Gemcitabine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2004
- Primary completion
- Nov 30, 2006
- Completion
- Nov 30, 2006
- Last update posted
- Oct 27, 2015
2005 – 2006
United States locations
- U.S. sites
- 31
- U.S. states
- 20
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Mobile | Alabama | — | — |
| Local Institution | Anchorage | Alaska | — | — |
| Local Institution | Bakersfield | California | — | — |
| Local Institution | Corona | California | — | — |
| Local Institution | Oxnard | California | — | — |
| Local Institution | San Diego | California | — | — |
| Local Institution | Whittier | California | — | — |
| Local Institution | Lakewood | Colorado | — | — |
| Local Institution | Boynton Beach | Florida | — | — |
| Local Institution | Brooksville | Florida | — | — |
| Local Institution | Inverness | Florida | — | — |
| Local Institution | Pembroke Pines | Florida | — | — |
| Local Institution | Austell | Georgia | — | — |
| Local Institution | Honolulu | Hawaii | — | — |
| Local Institution | Skokie | Illinois | — | — |
| Local Institution | Muncie | Indiana | — | — |
| Local Institution | Annapolis | Maryland | — | — |
| Local Institution | Frederick | Maryland | — | — |
| Local Institution | Rockville | Maryland | — | — |
| Local Institution | Plymouth | Massachusetts | — | — |
| Local Institution | Farmington | New Mexico | — | — |
| Local Institution | Armonk | New York | — | — |
| Local Institution | Stony Brook | New York | — | — |
| Local Institution | Gastonia | North Carolina | — | — |
| Local Institution | Wilmington | North Carolina | — | — |
| Local Institution | Bismarck | North Dakota | — | — |
| Local Institution | Cincinnati | Ohio | — | — |
| Local Institution | Portland | Oregon | — | — |
| Local Institution | Charleston | South Carolina | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | Vancouver | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00112346, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 27, 2015 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00112346 live on ClinicalTrials.gov.